Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer
Background: The relationship between the interleukin 17 (IL-17) family of cytokines and breast cancer has been widely studied in recent years. Many studies have revealed increased levels of the cytokine IL-17A in estrogen receptor (ER)-negative or triple-negative breast cancer. Upregulation of IL-17...
Main Authors: | Chong Shuai, Xinmei Yang, Hongming Pan, Weidong Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-09-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2020.582863/full |
Similar Items
-
Molecular Basis of Upregulation of IL-17 in Estrogen Model of Inflammation
by: Khan, Deena
Published: (2017) -
CD4+ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS
by: Merve Çebi, et al.
Published: (2020-05-01) -
Autoimmune diseases in the TH17 era
by: D. Mesquita Jr., et al.
Published: (2009-06-01) -
Mini Review: New Treatments in Psoriatic Arthritis. Focus on the IL-23/17 Axis
by: Lazaros I. Sakkas, et al.
Published: (2019-08-01) -
Role of PD1/PDL1 pathway, and TH17 and treg cells in maternal tolerance to the fetus
by: Sudipta Tripathi, et al.
Published: (2015-02-01)